𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder

✍ Scribed by George I. Papakostas; Maurizio Fava


Book ID
118436767
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
156 KB
Volume
17
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Milnacipran: The Clinical Properties of
✍ Y. Lecrubier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Milnacipran is a novel antidepressant agent which selectively inhibits the reuptake of serotonin and noradrenaline without directly aecting postsynaptic receptor sites. The biochemical and pharmacological pro®le of milnacipran suggested that the drug would be therapeutically eective and well tolerat